secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-09-12T23:59:59+00:00
Accession:  0001005286-24-000130
Event type: regulatory
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore Biomedical regains Nasdaq compliance, avoids delisting
---------------------------------------------------------------

- Filed overdue Q3 FY2023 and Q1/Q2 FY2024 10-Qs on Aug 8, 2024, and FY2024 10-K on Aug 26, 2024.
- Held 2024 annual meeting on Aug 15, 2024, curing Annual Meeting Rule deficiency.
- Nasdaq will monitor compliance until Sept 4, 2025; further failure to file timely could lead to delisting without cure period.
- Company's common stock remains listed on The Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000130/0001005286-24-000130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000130/lndc-20240911.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer